(secondQuint)Bioequivalence Study of Rivastigmine Capsules 1.

5 mg of Dr.

Reddy's Under Fed Conditions.

 Bioequivalence study of Rivastigmine Capsules 1.

5 mg and Exelon 1.

5 mg This was a single center, single-dose, open-label, randomized, 2-way crossover bioequivalence study,performed under fed conditions.

 The treatment phases were separated by a washout period of 7 days.

.

 Bioequivalence Study of Rivastigmine Capsules 1.

5 mg of Dr.

Reddy's Under Fed Conditions@highlight

The purpose of this bioequivalence study is to compare the test of Rivastigmine 1.

5 mg Capsules of Dr.

Reddy's Laboratories Limited with reference to Exelon 1.

5 mg of Novartis in Healthy Subjects Under Fed Conditions.

